Liquid Chromatography News and Research

RSS

B. oleronius from Demodex mites linked to rosacea development

The bacterium Bacillus oleronius from Demodex mites may play a role in the development of rosacea, suggest study findings.

22 Jun 2012

Cambridge facility to become worldwide hub for SAFC's chiral service

Sigma-Aldrich Corporation today announced that its custom manufacturing and services business unit, SAFC, will consolidate its global chiral chromatography screening and small scale purification operations and locate them at its Pharmorphix Solid State Research Laboratories in Cambridge, UK, to support its new integrated chiral chemistry offer.

11 Jun 2012

Rapid test to identify patients not responding to painkiller tramadol

French researchers have found a way to identify quickly the 5-10% of patients in whom the commonly used painkiller, tramadol, does not work effectively. A simple blood test can produce a result within a few hours, enabling doctors to switch a non-responding patient on to another painkiller, such as morphine, which will be able to work in these patients.

11 Jun 2012

Simple blood test can quickly identify 'poor metabolisers'

11 Jun 2012

New molecular test panel to enhance reliability of thyroid biopsy testing

Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced a new molecular test panel designed to help physicians determine if a thyroid gland is cancerous and requires surgical removal.

From Quest Diagnostics 2 Jun 2012

AB SCIEX, Prosolia enter technology license agreement

Prosolia, Inc. and AB SCIEX announced today that they have entered into a license agreement for technologies developed by Dr. Gary Van Berkel and his colleagues of Oak Ridge National Laboratory.

From Thermo Fisher Scientific Inc. 22 May 2012

BIOCRATES Life Sciences to introduce AbsoluteIDQ p180 and p150 research kits

Austrian BIOCRATES Life Sciences AG, prime developer of state-of-the-art metabolite biomarker panels, is about to launch new editions of two of its well-established research kit products -AbsoluteIDQ p180 and p150.

21 May 2012

Quest Diagnostics introduces four new tests panels for CAH

Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, has extended its endocrine diagnostics menu with the introduction of four new tests panels for congenital adrenal hyperplasia (CAH), an endocrine disorder found in newborns, children and women.

From Quest Diagnostics 19 May 2012

Final results from Alnylam’s ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.

11 May 2012

AB SCIEX introduces new triple quadrupole mass spectrometry instrumentation system

AB SCIEX, a global leader in life science analytical technologies, today announced the introduction of the AB SCIEX 4500 series, which is next-generation, mass spectrometry instrumentation that sets a new benchmark for routine quantitation and screening.

12 Mar 2012

Thermo Fisher Scientific launches Acclaim Surfactant Plus and MAbPac SCX-10 chromatography columns

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced new chromatography columns, the Thermo Scientific Acclaim Surfactant Plus and smaller-particle sized Thermo Scientific MAbPac SCX-10.

From Thermo Fisher Scientific Inc. 12 Mar 2012

Agilent's liquid chromatography and mass spec systems listed as Class I medical devices with FDA

Agilent Technologies Inc. (NYSE:A) today announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the U.S. Food and Drug Administration.

18 Jan 2012

New lab test quickly identifies bacterium responsible for staph infections

Researchers from the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) have developed a new laboratory test that can rapidly identify the bacterium responsible for staph infections. This new test takes advantage of unique isotopic labeling combined with specific bacteriophage amplification to rapidly identify Staphylococcus aureus.

13 Jan 2012

Agilent, Integrated Diagnostics partner to improve protein-based LC/MS assays

Agilent Technologies Inc. and Integrated Diagnostics today announced a strategic partnership to develop assays that detect major human diseases at very early stages to improve treatment outcomes.

11 Jan 2012

Pall launches new Acrodisc MS syringe filter

Pall Corporation, today introduced the Pall Acrodisc MS Syringe Filter the first syringe filter certified for low extractables in high performance liquid chromatography/mass spectrometry (LCMS) applications.

From Pall Corporation 5 Nov 2011

Over-the-counter 'thyroid support' supplements could be dangerous

People who use over-the-counter "thyroid support" supplements may be putting their health at risk, according to a study being presented at the annual meeting of the American Thyroid Association. The supplements contain varying amounts of two different kinds of thyroid hormones apparently derived in large part from chopped up animal thyroid glands, says the study's senior investigator, Victor Bernet, M.D., an endocrinologist at Mayo Clinic in Florida.

28 Oct 2011

World's first permanent food safety lab opens

The U.S. Food and Drug Administration, University of Maryland, their Joint Institute for Food Safety and Applied Nutrition and Waters Corporation today opened the International Food Safety Training Laboratory, a groundbreaking public-private partnership that applies government, university and private industry expertise and resources to the global food safety challenge.

15 Sep 2011

LC-MRM could provide better understanding of multiple myeloma drug resistance

12 Sep 2011

Moffitt researchers employ LC-MRM to detect acquired multiple myeloma drug resistance

"Acquired drug resistance" (ADR) is a major problem encountered in treating some forms of cancer. The ability to monitor the proteins involved in drug resistance has been a hurdle facing cancer researchers. However, a team of researchers at Moffitt Cancer Center, and colleagues, are pioneering promising research utilizing a monitoring technology that could provide a better understanding of ADR and assist in clinical decision-making for developing individualized patient treatments for multiple myeloma.

9 Sep 2011

Innovative UMD-based food safety program to launch on Sept. 15

Amid ongoing concerns about E. coli, Salmonella and other food-borne illnesses, a new facility will take a unique approach to make imports bound for the United States safer: Give foreign technicians who test those foods intensive, hands-on lab training in U.S. government methods, standards and technology, as well as acceptable alternatives.

8 Sep 2011